Yazar "Alswat, Khalid" için listeleme
-
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
Alqahtani, Saleh A.; Yılmaz, Yusuf; El-Kassas, Mohamed; Alswat, Khalid; Sanai, Faisal; AlZahrani, May; Abaalkhail, Faisal; AlShaikh, Manal; Stepanova, Maria; Younossi, Zobair M. (Wiley, 2024)Patients with chronic liver disease (CLD) experience health-related quality of life (HRQoL) and patient-reported outcomes (PROs) impairments. We assessed and identified predictors of HRQoL and PROs in CLD patients from ... -
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; Alqahtani, Saleh A.; Alswat, Khalid; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Fan, Jian-Gao; Zheng, Ming-Hua; El-Kassas, Mohamed; Castera, Laurent; Liu, Chun-Jen; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Allen, Alina M.; Lam, Brian; Treeprasertsuk, Sombat; Hameed, Saeed; Takahashi, Hirokazu; Kawaguchi, Takumi; Schattenberg, Jörn M.; Duseja, Ajay; Newsome, Phil N.; Francque, Sven; Spearman, C. Wendy; Castellanos Fernández, Marlen I.; Burra, Patrizia; Roberts, Stuart K.; Chan, Wah-Kheong; Arrese, Marco; Silva, Marcelo; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart; Fuchs, Michael; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Eskridge, Wayne; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Yu, Ming-Lung; Gerber, Lynn; Fornaresio, Lisa; Nader, Fatema; Henry, Linda; Racila, Andrei; Golabi, Pegah; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2023)Background & Aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this crosssectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease ... -
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; AlQahtani, Saleh A.; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Alswat, Khalid; Yu, Ming-Lung; Liu, Chun-Jen; Fan, Jian-Gao; Zheng, Ming-Hua; Burra, Patrizia; Francque, Sven M.; Castera, Laurent; Schattenberg, Jörn M.; Newsome, Philip N.; Allen, Alina M.; El-Kassas, Mohamed; Treeprasertsuk, Sombat; Hameed, Saeed; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Takahashi, Hirokazu; Kawaguchi, Takumi; Castellanos Fernández, Marlen I.; Duseja, Ajay; Arrese, Marco; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart C.; Fuchs, Michael; Eskridge, Wayne; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Gerber, Lynn; Lam, Brian; Fornaresio, Lisa; Nader, Fatema; Spearman, C. Wendy; Roberts, Stuart K.; Chan, Wah-Kheong; Silva, Marcelo; Racila, Andrei; Golabi, Pegah; Ananchuensook, Prooksa; Henry, Linda; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2024)Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality ... -
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region
Alqahtani, Saleh A.; Yılmaz, Yusuf; El-Kassas, Mohamed; Alswat, Khalid; Mawardi, Mohamed; Sanai, Faisal M.; Abaakhail, Faisal; Alghamdi, Saad; Al-Hamoudi, Waleed K; Nader, Fatema; Younossi, Zobair M. (Elsevier, 2024)Introduction and Objectives: Given the substantial burden of metabolic dysfunction-associated steatotic liver disease (MASLD), there is an urgent need to assess knowledge and awareness levels among physicians. We assessed ... -
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa
Younossi, Zobair M.; Golabi, Pegah; Paik, James; Owrangi, Soroor; Yılmaz, Yusuf; El-Kassas, Mohamed; Alswat, Khalid; Alqahtani, Saleh A. (Wiley, 2024)Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is common and closely associated with type 2 diabetes (T2D). We assessed ... -
Risk stratification of patients with metabolic dysfunction-associated steatotic liver disease steatohepatitis, fibrosis, and hepatocellular carcinoma
El-Kassas, Mohamed; Othman, Heba A.; Elbadry, Mohamed; Alswat, Khalid; Yılmaz, Yusuf (Elsevier, 2024)The metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is increasing globally, creating a growing public health concern. Metabolic disorders such ...
